These results show that adding supervised exercise during GLP-1 use improves weight loss maintenance after treatment termination
NAD and MNM
At 1/20 the normal rescue dose, the hepatocyte curve descends to the 30% level so the survival of the patient is unclear
Diabetes Obes Metab 22(12):24872492 Verma S, Bhatta M, Davies M, Deanfield JE, Garvey WT, Jensen C, et al (2023) Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials
The potential risks include misled users forgoing effective, medically approved options while spending money on products that dont deliver on their promises